Global

Surgery Experts

Thomas Hugh

Professor
Surgery
The University of Sydney
Australia

Biography

 Tom Hugh is Chair in Surgery at the Northern Clinical School, University of Sydney, and head of the Upper GI Surgical Unit at Royal North Shore Hospital. His clinical interests include the management of patients with benign and malignant liver disease, gallbladder disease and abdominal wall hernias. He is passionate about clinical audit and is responsible for establishing and embedding prospective total practice audit in the Upper GI Surgical unit at RNSH. He developed and introduced the novel idea of establishing a dedicated Surgical Audit Unit (SAU) for the Division of Surgery at RNSH. His main clinical research focus is on long-term outcomes after resection for colorectal liver metastases. His laboratory research is in "stromal markers in primary and metastatic colorectal cancer, Investigating biological nanoparticles for the delivery of chemotherapeutic drugs in cancer, and the prognostic utility of tumour biomarkers in pancreatic ductal adenocarcinoma". He has been involved in the development of a novel xenograft platform to examine the tumour microenvironment in patients with colorectal liver metastases through the CanSur research group in the Kolling Institute. He is a long-standing board member of CanSur, a not-for-profit surgical research foundation based at Royal North Shore Hospital. He is also a current executive board member of the Australian and New Zealand Hepato-Pancreato-Biliary Association. He is the founder and director of the Surgical Education, Research and Training (SERT) Institute at Royal North Shore Hospital.

Research Interest

Long-term outcomes after resection for colorectal liver metastases Stromal markers in primary and metastatic colorectal cancer Investigating biological nanoparticles for the delivery of chemotherapeutic drugs in cancer A novel xenograft platform to examine the tumour microenvironment in patients with colorectal liver metastases through the CanSur research group in the Kolling Institute. Clinical outcomes of patients with primary liver bile duct cancer Qulaity of Life studies after liver cancer surgery Proteonomics of hepatocellular cancer Long term follow-up after hernia surgery

Global Experts from Australia

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America